# Cardiovascular Effects of Racemic Epinephrine Pellets

> **NCT04688346** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Washington** · enrollment: 13 (actual)

## Conditions studied

- Epinephrine Causing Adverse Effects in Therapeutic Use

## Interventions

- **DRUG:** HemeRX epinephrine pellets

## Key facts

- **NCT ID:** NCT04688346
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-10
- **Primary completion:** 2019-11-30
- **Final completion:** 2019-11-30
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2021-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04688346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04688346, "Cardiovascular Effects of Racemic Epinephrine Pellets". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04688346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*